A few days ago, Baker Hughes (NYSE:BHI) came out with some data regarding the global rig count. During a time when oil production continues to fall in the U.S., as well as in other countries in the world like China and Venezuela, but prices are rising, fears are arising that the uptick in the rig count will result in more production coming on-line moving forward – which, if true, would prolong....More>>>
As cryptocurrencies like Bitcoin gain both public awareness and record-high trading rounds, investors of every stripe are looking to alternative investments rooted in the digital marketplace. But if December’s sudden and unexpected downturn is of any consequence, it should put traders on alert that these cryptocurrencies may not be the lucrative long-term cash cow speculators raved about just....More>>>
Finisar (NASDAQ:FNSR) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.
According to Zacks, “FINISAR CORP. is a provider of fiber optic subsystems and network test and monitoring systems which enable high-speed data communications over local area networks, or LANs,....More>>>
An Indian IT behemoth says it has cut its U.S. work visa applications by two-thirds.
Tata Consultancy Services is one of the largest petitioners of H-1Bs, the high-skilled work visa favored by the tech industry. Its outsourcing operations cater to the IT needs of businesses around the world. To do so, it largely relies on getting work visas for Indian tech workers so they can consult with....More>>>
Equities research analysts expect that AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will post $159.34 million in sales for the current fiscal quarter, Zacks reports. Five analysts have made estimates for AMAG Pharmaceuticals’ earnings, with the highest sales estimate coming in at $164.12 million and the lowest estimate coming in at $150.80 million. AMAG Pharmaceuticals posted sales of $158.39....More>>>